A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

NCT00333112 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

398

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence

Interventions

DRUG: solifenacin succinate
DRUG: tamsulosin
DRUG: placebo

Sponsor

Astellas Pharma Inc